{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:34:41Z","timestamp":1793144081807,"version":"4.5.0"},"reference-count":139,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.semarthrit.2013.09.005","type":"journal-article","created":{"date-parts":[[2013,10,5]],"date-time":"2013-10-05T16:46:41Z","timestamp":1380991601000},"page":"613-626","source":"Crossref","is-referenced-by-count":250,"title":["Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: A systematic literature review"],"prefix":"10.1016","volume":"43","author":[{"given":"Camille","family":"Roubille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boulos","family":"Haraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2013.09.005_bib1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/BOR.0b013e32835f693f","article-title":"Extra-articular rheumatoid arthritis","volume":"25","author":"Turesson","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib2","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/art.22504","article-title":"Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists","volume":"56","author":"Curtis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/annrheumdis-2012-201969","article-title":"Incidences of overall and site specific cancers in TNFalpha inhibitor treated patients with rheumatoid arthritis and other arthritides\u2014a follow-up study from the DANBIO Registry","volume":"72","author":"Dreyer","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib4","first-page":"89","article-title":"Gold-induced hypersensitivity pneumonitis in a patient with rheumatoid arthritis","volume":"7","author":"Agarwal","year":"1989","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1517\/14740338.4.4.723","article-title":"Methotrexate pulmonary toxicity","volume":"4","author":"Lateef","year":"2005","journal-title":"Expert Opin Drug Saf"},{"issue":"b2535","key":"10.1016\/j.semarthrit.2013.09.005_bib6","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"339","author":"Moher","year":"2009","journal-title":"Br Med J"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib7","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/art.1780261015","article-title":"Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis","volume":"26","author":"Cannon","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib8","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/art.1780261016","article-title":"Methotrexate pneumonitis after low-dose therapy for rheumatoid arthritis","volume":"26","author":"Engelbrecht","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib9","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/archinte.1985.00360110105023","article-title":"Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis","volume":"145","author":"St Clair","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/thx.41.9.703","article-title":"Low dose methotrexate pneumonitis in rheumatoid arthritis","volume":"41","author":"Louie","year":"1986","journal-title":"Thorax"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0049-0172(87)90021-7","article-title":"Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate","volume":"16","author":"Carson","year":"1987","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib12","first-page":"1164","article-title":"Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature","volume":"14","author":"Searles","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib13","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/art.1780311221","article-title":"Fatal methotrexate pneumonitis in rheumatoid arthritis","volume":"31","author":"Newman","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/ard.47.9.784","article-title":"Life threatening acute pneumonitis during low dose methotrexate treatment for rheumatoid arthritis: a case report and review of the literature","volume":"47","author":"Ridley","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archinte.1989.00390030137027","article-title":"Toxicity of methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A case-control study of 131 patients","volume":"149","author":"McKendry","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/ard.51.2.272","article-title":"Successful reintroduction of methotrexate after pneumonitis in two patients with rheumatoid arthritis","volume":"51","author":"Cook","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/thx.47.8.628","article-title":"Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports","volume":"47","author":"Hargreaves","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/rheumatology\/31.5.356","article-title":"Methotrexate pneumonitis in rheumatoid arthritis\u2014a dramatic response to treatment","volume":"31","author":"Mulherin","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/BF02231787","article-title":"Concurrent acute megaloblastic anaemia and pneumonitis: a severe side-effect of low-dose methotrexate therapy during rheumatoid arthritis","volume":"12","author":"Bolla","year":"1993","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/thx.48.2.191-b","article-title":"Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis","volume":"48","author":"Hassan","year":"1993","journal-title":"Thorax"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib21","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1378\/chest.104.5.1620","article-title":"Pneumonitis complicating low-dose methotrexate therapy for rheumatoid arthritis. Discrepancies between lung biopsy and bronchoalveolar lavage findings","volume":"104","author":"Leduc","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/ard.53.7.479","article-title":"Methotrexate-related pulmonary complications in patients with rheumatoid arthritis: cluster of five cases in a period of three months","volume":"53","author":"Barrera","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/rheumatology\/35.5.441","article-title":"Occurrence of pulmonary complications during methotrexate therapy in rheumatoid arthritis","volume":"35","author":"Hilliquin","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib24","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/art.1780401016","article-title":"Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review","volume":"40","author":"Kremer","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib25","first-page":"2299","article-title":"Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis","volume":"24","author":"Ohosone","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/BF02238967","article-title":"Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature","volume":"16","author":"Salaffi","year":"1997","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib27","first-page":"355","article-title":"Rheumatoid arthritis associated with methotrexate-induced pneumonitis: improvement with i.v. cyclophosphamide therapy","volume":"17","author":"Suwa","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1034\/j.1399-3003.2000.15b25.x","article-title":"Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients","volume":"15","author":"Imokawa","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib29","first-page":"249","article-title":"Two fatal cases of methotrexate-induced interstitial pneumonitis","volume":"40","author":"Matsushima","year":"2002","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib30","first-page":"137","article-title":"Methotrexate pneumonitis in a patient with rheumatoid arthritis","volume":"36","author":"Hsu","year":"2003","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/s10165-007-0578-7","article-title":"Methotrexate pneumonia lacking dyspnea and radiographic interstitial patterns during treatment for early rheumatoid arthritis: bronchoalveolar lavage and transbronchial lung biopsy in a differential diagnosis","volume":"17","author":"Cho","year":"2007","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/rheumatology\/kem230","article-title":"Methotrexate pneumonitis precipitated by switching from oral to parenteral administration","volume":"47","author":"Collins","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00007611-197903000-00023","article-title":"Methotrexate-induced diffuse interstitial pulmonary fibrosis","volume":"72","author":"Bedrossian","year":"1979","journal-title":"South Med J"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib34","first-page":"1766","article-title":"Fatal pulmonary fibrosis complicating low dose methotrexate therapy for rheumatoid arthritis","volume":"22","author":"van der Veen","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib35","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/rheumatology\/35.5.446","article-title":"Pulmonary function in rheumatoid arthritis treated with low-dose methotrexate: a longitudinal study","volume":"35","author":"Beyeler","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib36","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1378\/chest.109.4.933","article-title":"Pulmonary function in patients receiving long-term low-dose methotrexate","volume":"109","author":"Cottin","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib37","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/rheumatology\/41.3.262","article-title":"Investigation of the chronic pulmonary effects of low-dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HRCT scanning and pulmonary function tests","volume":"41","author":"Dawson","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00296-002-0227-6","article-title":"Effect of methotrexate on pulmonary function in patients with rheumatoid arthritis\u2014a prospective study","volume":"22","author":"Khadadah","year":"2002","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib39","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2169\/internalmedicine.43.1201","article-title":"Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction","volume":"43","author":"Kamata","year":"2004","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.rmedx.2005.03.005","article-title":"A case of acute pneumonitis associated with leflunomide treatment","volume":"1","author":"Collier","year":"2005","journal-title":"Respiry Med Extra"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib41","first-page":"1160","article-title":"Leflunomide induced acute interstitial pneumonia","volume":"32","author":"Takeishi","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib42","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/rheumatology\/kei076","article-title":"Lethal pneumonitis under leflunomide therapy","volume":"44","author":"Vallbracht","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib43","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2169\/internalmedicine.45.1455","article-title":"Leflunomide-induced pneumonitis in a patient with rheumatoid arthritis","volume":"45","author":"Hirabayashi","year":"2006","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib44","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/s10165-006-0506-2","article-title":"Leflunomide-related acute interstitial pneumonia in two patients with rheumatoid arthritis: autopsy findings with a mosaic pattern of acute and organizing diffuse alveolar damage","volume":"16","author":"Ochi","year":"2006","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1445-5994.2006.01035.x","article-title":"Pneumonitis associated with leflunomide: a profile of New Zealand and Australian reports","volume":"36","author":"Savage","year":"2006","journal-title":"Intern Med J"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib46","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/art.22666","article-title":"Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis","volume":"56","author":"Ju","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib47","first-page":"1934","article-title":"Hypersensitivity pneumonitis associated with leflunomide therapy","volume":"34","author":"Martin","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/s10165-007-0014-z","article-title":"Leflunomide-induced lung injury that developed after its withdrawal, coinciding with peripheral blood lymphocyte count decrease","volume":"18","author":"Otsuka","year":"2008","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib49","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1378\/chest.08-1501","article-title":"An elderly man with rheumatoid arthritis and dyspnea","volume":"135","author":"Nesheiwat","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib50","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/RHU.0b013e3181c3f87e","article-title":"Successful treatment of leflunomide-induced acute pneumonitis with cholestyramine wash-out therapy","volume":"15","author":"Wong","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib51","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/rheumatology\/40.6.712","article-title":"Gold-induced pneumonitis: computed tomography findings in a patient with rheumatoid arthritis","volume":"40","author":"Sinha","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib52","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00296-003-0293-4","article-title":"Fatal gold-induced pneumonitis","volume":"23","author":"Soler","year":"2003","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib53","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3899\/jrheum.111415","article-title":"Pulmonary toxicity after initiation of azathioprine for treatment of interstitial pneumonia in a patient with rheumatoid arthritis","volume":"39","author":"Ishida","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib54","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/rheumatology\/29.3.222","article-title":"Fibrosing alveolitis due to sulphasalazine in a patient with rheumatoid arthritis","volume":"29","author":"Boyd","year":"1990","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib55","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1378\/chest.101.4.1033","article-title":"Sulfasalazine-induced pulmonary disease","volume":"101","author":"Hamadeh","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib56","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1440-1592.2003.00276.x","article-title":"Acute organizing interstitial pneumonia and interstitial nephritis due to salazosulfapyridine in a patient with rheumatoid arthritis","volume":"52","author":"Ogawa","year":"2003","journal-title":"Allergol Int"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib57","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10067-003-0848-5","article-title":"Bronchiolitis obliterans organizing pneumonia associated with sulfasalazine in a patient with rheumatoid arthritis","volume":"23","author":"Ulubas","year":"2004","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib58","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/art.10803","article-title":"Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis","volume":"47","author":"Kramer","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib59","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/art.11187","article-title":"Comment on methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis","volume":"49","author":"Courtney","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib60","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/03009740410005836","article-title":"Severe interstitial pneumonitis associated with infliximab therapy","volume":"33","author":"Chatterjee","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib61","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1136\/bmj.329.7477.1266","article-title":"Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab","volume":"329","author":"Ostor","year":"2004","journal-title":"Br Med J"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib62","first-page":"1917","article-title":"Infliximab-associated pneumonitis in rheumatoid arthritis","volume":"33","author":"Hennum","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib63","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/rheumatology\/kel220","article-title":"Adalimumab-associated pulmonary fibrosis","volume":"45","author":"Huggett","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib64","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/rheumatology\/kel090","article-title":"Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment","volume":"45","author":"Lindsay","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib65","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/s10165-006-0491-5","article-title":"Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor alpha-neutralizing antibody","volume":"16","author":"Mori","year":"2006","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib66","first-page":"622","article-title":"Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis","volume":"33","author":"Ostor","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib67","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/01.smj.0000223696.21984.1f","article-title":"Enbrel-induced interstitial lung disease","volume":"99","author":"Quintos-Macasa","year":"2006","journal-title":"South Med J"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/art.21716","article-title":"Pulmonary fibrosis in a patient with rheumatoid arthritis treated with adalimumab","volume":"55","author":"Schoe","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib69","first-page":"1189","article-title":"Interstitial pneumonitis associated with infliximab therapy","volume":"33","author":"Villeneuve","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib70","first-page":"1151","article-title":"Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis","volume":"34","author":"Hagiwara","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib71","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jbspin.2007.04.028","article-title":"Exacerbation of interstitial lung disease during etanercept therapy: two cases","volume":"75","author":"Tournadre","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib72","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00296-009-0931-6","article-title":"Interstitial pneumonitis associated with infliximab therapy without methotrexate treatment","volume":"30","author":"Taki","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib73","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/RHU.0b013e3181df8361","article-title":"Adalimumab-induced acute pneumonitis in a patient with rheumatoid arthritis","volume":"16","author":"Dascalu","year":"2010","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib74","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/s10165-010-0327-1","article-title":"Organizing pneumonia in a patient with rheumatoid arthritis treated with etanercept","volume":"20","author":"Sakaida","year":"2010","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib75","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3109\/s10165-010-0308-4","article-title":"A case of adalimumab-associated interstitial pneumonia with rheumatoid arthritis","volume":"20","author":"Yamazaki","year":"2010","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib76","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2169\/internalmedicine.50.4748","article-title":"Adalimumab-induced interstitial pneumonia with an improvement of pre-existing rheumatoid arthritis-associated lung involvement","volume":"50","author":"Komiya","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib77","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00296-009-1350-4","article-title":"Etanercept induced organizing pneumonia in a patient with rheumatoid arthritis","volume":"32","author":"Cho","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib78","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2710.2010.01234.x","article-title":"Eternacept for the treatment of patients with rheumatoid arthritis and concurrent interstitial lung disease","volume":"37","author":"Horai","year":"2012","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib79","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/rheumatology\/ker452","article-title":"Fatal fibrosing alveolitis with certolizumab","volume":"51","author":"Millar","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib80","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/rheumatology\/ker309","article-title":"Interstitial lung disease following certolizumab pegol","volume":"51","author":"Pearce","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib81","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/ket175","article-title":"A case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis","author":"Glaspole","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib82","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.122.3.1093","article-title":"Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition","volume":"122","author":"Vassallo","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib83","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1183\/09031936.04.00076904","article-title":"Infliximab treatment in a patient with rheumatoid arthritis and pulmonary fibrosis","volume":"24","author":"Bargagli","year":"2004","journal-title":"Eur Respir J."},{"key":"10.1016\/j.semarthrit.2013.09.005_bib84","first-page":"23","article-title":"Infliximab therapy in pulmonary fibrosis associated with collagen vascular disease","volume":"25","author":"Antoniou","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib85","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.21778","article-title":"The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial","volume":"54","author":"Emery","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib86","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jbspin.2007.10.009","article-title":"Organizing pneumonia after rituximab therapy: two cases","volume":"75","author":"Soubrier","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib87","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/rheumatology\/ker290","article-title":"Non-infectious pulmonary toxicity of rituximab: a systematic review","volume":"51","author":"Hadjinicolaou","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib88","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/art.20303","article-title":"Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial","volume":"50","author":"Nishimoto","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib89","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","article-title":"Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial","volume":"371","author":"Smolen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib90","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/s10165-008-0125-1","volume":"19","author":"Nishimoto","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib91","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2169\/internalmedicine.50.5497","article-title":"A case of organizing pneumonia induced by tocilizumab","volume":"50","author":"Ikegawa","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib92","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1007\/s00296-010-1525-z","article-title":"A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab","volume":"32","author":"Kawashiri","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib93","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2177\/jsci.35.433","article-title":"A case of rheumatoid arthritis complicated with deteriorated interstitial pneumonia after the administration of abatacept","volume":"35","author":"Wada","year":"2012","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib94","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/jama.1969.03150180053011","article-title":"Acute lymphocytic leukemia in children: maintenance therapy with methotrexate administered intermittently. Acute Leukemia Group B","volume":"207","year":"1969","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib95","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/ard.2008.093690","article-title":"Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research","volume":"68","author":"Salliot","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib96","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/rheumatology\/keh512","article-title":"The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions","volume":"44","author":"Kinder","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib97","first-page":"S918","article-title":"Methotrexate and interstitial lung disease in rheumatoid arthritis\u2014a systematic literature review and meta-analysis","volume":"64","author":"Conway","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib98","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0889-857X(05)70366-5","article-title":"Methotrexate pulmonary toxicity","volume":"23","author":"Cannon","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib99","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0009-9260(05)80161-8","article-title":"High-resolution computed tomography of drug-induced lung disease","volume":"46","author":"Padley","year":"1992","journal-title":"Clin Radiol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00005382-200310000-00004","article-title":"Methotrexate-induced pulmonary injury: serial CT findings","volume":"18","author":"Arakawa","year":"2003","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib101","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thx.52.4.377","article-title":"Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis","volume":"52","author":"Schnabel","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib102","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000079633","article-title":"Interstitial lung disease induced by drugs and radiation","volume":"71","author":"Camus","year":"2004","journal-title":"Respiration"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib103","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7326\/0003-4819-127-5-199709010-00003","article-title":"Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group","volume":"127","author":"Alarcon","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib104","first-page":"1043","article-title":"The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis","volume":"22","author":"Golden","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib105","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(04)15527-X","article-title":"Japan deaths spark concerns over arthritis drug","volume":"363","author":"McCurry","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib106","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/s10165-005-0387-9","article-title":"Leflunomide-related lung injury in patients with rheumatoid arthritis: imaging features","volume":"15","author":"Sakai","year":"2005","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib107","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/art.21806","article-title":"Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis","volume":"54","author":"Suissa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib108","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/annrheumdis-2012-201944","article-title":"HLA-A\u204e31:01 and methotrexate-induced interstitial lung disease in Japanese rheumatoid arthritis patients: a multidrug hypersensitivity marker?","volume":"72","author":"Furukawa","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib109","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/rheumatology\/kep052","article-title":"Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis","volume":"48","author":"Sawada","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib110","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/rheumatology\/kep227","article-title":"Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis","volume":"48","author":"Sato","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib111","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/rheumatology\/kep050","article-title":"Clinical expression of leflunomide-induced pneumonitis","volume":"48","author":"Chikura","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib112","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/ard.2007.072967","article-title":"Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis","volume":"67","author":"Takeuchi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib113","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3899\/jrheum.080791","article-title":"Postmarketing surveillance of the safety and effectiveness of etanercept in Japan","volume":"36","author":"Koike","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib114","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/03009740601153774","article-title":"Rheumatoid arthritis treatment and the risk of severe interstitial lung disease","volume":"36","author":"Wolfe","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib115","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semarthrit.2010.11.002","article-title":"Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases","volume":"41","author":"Perez-Alvarez","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib116","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/MCP.0b013e3283483ea5","article-title":"Biological treatments and connective tissue disease associated interstitial lung disease","volume":"17","author":"Panopoulos","year":"2011","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib117","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/s10165-010-0406-3","article-title":"Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis","volume":"21","author":"Koike","year":"2011","journal-title":"Mod Rheumatol"},{"issue":"Suppl. 10","key":"10.1016\/j.semarthrit.2013.09.005_bib118","first-page":"S573","article-title":"The incidence of exacerbation of pre-existing interstitial lung disease (ILD) is higher in TNF blockers than in non-TNF blockers in RA","volume":"64","author":"Nakashita","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib119","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.semarthrit.2009.09.001","article-title":"Tumor necrosis factor inhibitors and lung disease: a paradox of efficacy and risk","volume":"40","author":"Khasnis","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib120","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/s10165-011-0541-5","article-title":"Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients","volume":"22","author":"Koike","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib121","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MAJ.0b013e31824c07e8","article-title":"Infliximab-induced nonspecific interstitial pneumonia","volume":"344","author":"Sen","year":"2012","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib122","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMcpc0806979","article-title":"Case records of the Massachusetts General Hospital. Case 33-2008. A 63-year-old woman with dyspnea on exertion","volume":"359","author":"Wiener","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib123","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/ard.2005.044453","article-title":"Fatal exacerbation of fibrosing alveolitis associated with systemic sclerosis in a patient treated with adalimumab","volume":"65","author":"Allanore","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib124","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/ard.2009.120626","article-title":"Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib125","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/pds.3409","article-title":"Association between anti-TNF-alpha therapy and interstitial lung disease","volume":"22","author":"Herrinton","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib126","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4049\/jimmunol.170.1.567","article-title":"Repression of bleomycin-induced pneumopathy by TNF","volume":"170","author":"Kuroki","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib127","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1164\/ajrccm\/138.3.652","article-title":"Tumor necrosis factor interacts with interleukin-1 and interferons to inhibit fibroblast proliferation via fibroblast prostaglandin-dependent and -independent mechanisms","volume":"138","author":"Elias","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib128","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1582-4934.2008.00647.x","article-title":"TNF-alpha induces TGF-beta1 expression in lung fibroblasts at the transcriptional level via AP-1 activation","volume":"13","author":"Sullivan","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib129","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1172\/JCI118029","article-title":"Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis","volume":"96","author":"Miyazaki","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib130","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1183\/09031936.00080209","article-title":"Rituximab-induced lung disease: a systematic literature review","volume":"35","author":"Liote","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib131","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/art.21758","article-title":"Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia","volume":"54","author":"Atkins","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 3","key":"10.1016\/j.semarthrit.2013.09.005_bib132","first-page":"71","article-title":"Safety of rituximab in patients with rheumatoid arthritis and concomitant lung disease","volume":"70","author":"Dass","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.semarthrit.2013.09.005_bib133","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/annrheumdis-2013-eular.1355","article-title":"Safety and efficacy of rituximab in patients with rheumatoid arthritis and lung involvement","volume":"72","author":"Becerra","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 10","key":"10.1016\/j.semarthrit.2013.09.005_bib134","first-page":"2212","article-title":"Open-label pilot study of the safety and clinical effects of rituximab in patients with rheumatoid arthritis-associated interstitial pneumonia","volume":"63","author":"Matteson","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib135","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/BOR.0b013e3282f798ed","article-title":"Lung disease in rheumatoid arthritis","volume":"20","author":"Nannini","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib136","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 2","key":"10.1016\/j.semarthrit.2013.09.005_bib137","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1038\/sj.bjc.6602064","article-title":"Diagnosis and management of drug-associated interstitial lung disease","volume":"91","author":"Muller","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib138","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/rheumatology\/kel075","article-title":"Drug-related pulmonary problems in patients with rheumatoid arthritis","volume":"45","author":"Saravanan","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2013.09.005_bib139","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/BOR.0b013e3282f4b392","article-title":"The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis","volume":"20","author":"Askling","year":"2008","journal-title":"Curr Opin Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017213002011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017213002011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T06:56:59Z","timestamp":1539327419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017213002011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":139,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0049017213002011"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2013.09.005","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}